Treatment with Noripurum EV is effective and safe in pediatric patients with inflammatory bowel disease and iron deficiency anemia.

Objectives: To evaluate the therapeutic response and adverse effects of Noripurum EV in children and adolescents with inflammatory bowel disease (IBD) and iron deficiency anemia.

Materials And Methods: Cohort study involving patients with Crohn's disease (CD) and ulcerative colitis (UC) who received treatment for iron deficiency anemia with Noripurum EV. Anemia was defined according to WHO 2011 criteria.